A key deadline for the incoming administration is Feb. 1, 2025, by which Medicare must select up to 15 high-cost drugs to negotiate prices on. While the Biden administration may select these drugs ...
Zacks.com on MSN11h
Elite Pharmaceuticals' Stock Up Despite Q2 Earnings DeclineShares of Elite Pharmaceuticals, Inc. ELTP have gained 12.2% since the company released its earnings for the quarter ended ...
BTIG raised the firm’s price target on Syndax (SNDX) to $43 from $35 and keeps a Buy rating on the shares. The firm cites the company having ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback